Franklin Resources
MXCT icon

Franklin Resources’s MaxCyte MXCT Stock Holding History

Franklin Resources’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-67,131
Closed -$183K – 3095
2025
Q1 		$183K Sell
67,131
-118
-0.2% -$465 ﹤0.01% 2705
2024
Q4 		$280K Hold
67,249
– – ﹤0.01% 2531
2024
Q3 		$260K Buy
+67,249
New +$283K ﹤0.01% 2544
2024
Q1 		– Sell
-44,818
Closed -$211K – 2926
2023
Q4 		$211K Buy
44,818
+222
+0.5% +$864 ﹤0.01% 2331
2023
Q3 		$139K Buy
44,596
+1,668
+4% +$6.71K ﹤0.01% 2407
2023
Q2 		$197K Buy
+42,928
New +$197K ﹤0.01% 2386

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources's MXCT Position: Q2 2025 in Review

Franklin Resources sold out of MaxCyte (MXCT) in Q2 2025, closing a stake of 67,131 shares — an estimated $183K sold.

Franklin Resources first reported a position in MXCT in Q2 2023 and held it in 6 quarters. The position peaked at $280K in Q4 2024. 120 funds tracked by Wall St. Rank hold MXCT as of Q2 2025.

  • Franklin Resources reported no remaining MaxCyte position as of Q2 2025 after selling out during the quarter.
  • Franklin Resources sold 67,131 MaxCyte shares in Q2 2025, an estimated $183K.
  • Franklin Resources first reported a position in MaxCyte in Q2 2023 and held it in 6 quarters.
  • Franklin Resources's MaxCyte position peaked at $280K in Q4 2024.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q2 2025.

Based on Franklin Resources's 13F filing for Q2 2025, filed 12 Aug 2025.